Gynecologic Oncology Reports (Dec 2014)

Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation

Yasmin A. Lyons,
Michael Frumovitz,
Pamela T. Soliman

Affiliations

Yasmin A. Lyons: Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, TX, United States
Michael Frumovitz: Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Pamela T. Soliman: Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

DOI: https://doi.org/10.1016/j.gore.2014.09.003
Journal volume & issue: Vol. 10, no. C
pp. 28 – 29

Abstract

No abstracts available.

Published in Gynecologic Oncology Reports

ISSN: 2352-5789 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Gynecology and obstetrics; Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://www.journals.elsevier.com/gynecologic-oncology-reports/

About the journal